Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · AAREYDRUGS

AAREYDRUGS

HealthcarePharmaceuticals & Biotechnology₹306 cr market cap
₹110.34 ▲ +2.4% today As of 19 Nov 2026
52-week low ₹50.7552-week high ₹115.15

-6.4% from the 52-week high · +112.3% above the low

Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is also engaged in the trading of industrial solvents and chemicals. The firm is manufacturing intermediates, which include Mono Methyl Urea, Die Methyl Urea, Ortho Para Nitro Anisole, 2 Bromomethyl 1,3 Dioxalane and Uracile. The Company’s API includes Metformin Hydrochloric Acid (HCL), Mefenamic Acid and Doxophylline. The firm's chemical and solvents include aromatics chemicals, chemical acid, chloralkaline, industrial alcohols, industrial ketones, glycols and glycol ethers, fiber intermediates, industrial amines, acetates and esters, industrial oleochemicals, chlorinated solvents, industrial intermediates, industrial olefines, industrial phosphates, industrial fertilizers, industrial monomers and industrial chemicals.

The short version. Promoter holding was 41.45% in Sep 2026, down 3.35 points over 8 quarters.

1 · The price

How has the stock traded?

AAREYDRUGS trades 6.4% below its 52-week high and 112.3% above its 52-week low.

Change over period: —

1M-5.4%
3M+30.5%
6M+26.7%
1Y+13.3%

4 · The owners

Who holds it, and are they adding?

Promoter holding41.45%

Down 3.35 pts over 8 quarters.

Foreign institutions4.27%

Up 1.93 pts over 8 quarters.

Domestic institutions1.44%

Up 1.44 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter44.844.844.844.839.0637.7137.7141.45-3.35
FII2.342.341.971.133.864.184.84.27+1.93
DII000001.621.621.44+1.44
Public52.8652.8653.2354.0757.0956.4955.8652.83-0.03

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for AAREYDRUGS are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about AAREYDRUGS

What is the AAREYDRUGS share price?

AAREYDRUGS (AAREYDRUGS) last closed at ₹110.34, up 2.4% on the day. Its 52-week range is ₹50.75 to ₹115.15.

What is the market cap of AAREYDRUGS?

AAREYDRUGS has a market capitalisation of about ₹306 crore. Its price-to-earnings ratio is 83.2.

How are AAREYDRUGS's latest results?

Promoter holding was 41.45% in Sep 2026, down 3.35 points over 8 quarters.

Who owns AAREYDRUGS?

As of Sep 2026, shareholding was: Promoter 41.45%, FII 4.27%, DII 1.44%, Public 52.83%.

How many mutual funds hold AAREYDRUGS?

0 mutual fund schemes held AAREYDRUGS in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 13 Dec 2018 · Interim Dividend - Rs. 0.1

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.